Summer Street Research Partners leverages the healthcare expertise of our senior equity research analysts, our investment bankers, and the more than 4,000 physicians and industry professionals working with us through our Medical Consulting Referral, Inc. to identify, work with, and raise the awareness of growing healthcare companies. We view investment banking as a long-term alliance between us and our clients, as well as an avenue to raise funds and help develop strategic partnerships to fuel our clients’ success.

Prior to joining Summer Street Research Partners, Matt Dormer worked for Wellington Management Company in the Portfolio Advisor Group and was formerly an associate analyst covering the biotechnology sector at Fulcrum Global Partners in New York City. Prior to his experience in biotech equity research, Mr. Dormer was a scientist for a start-up biotech company, and a research associate and teaching fellow at Harvard University,  where he conducted research on tumor suppressor genes.  Dormer has an MBA in finance from Northeastern University and a BS in Biology from Davidson College.